Difference between revisions of "PSMG3-AS1"
(Created page with "PSMG3-AS1 and miR-449b-5p interact in lung cancer.<ref name="ref1" /> ==Annotated Information== ===Name=== Approv...") |
(→Regulation) |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
− | PSMG3-AS1 | + | LncRNA PSMG3-AS1 can suppress cancer cell proliferation in lung adenocarcinoma<ref name="ref1" /> |
==Annotated Information== | ==Annotated Information== | ||
===Name=== | ===Name=== | ||
Line 6: | Line 6: | ||
Approved name:PSMG3 antisense RNA 1 (head to head) | Approved name:PSMG3 antisense RNA 1 (head to head) | ||
− | HGNC ID | + | HGNC ID:22230 |
Alias symbol:KIAA1908 | Alias symbol:KIAA1908 | ||
Line 16: | Line 16: | ||
Please input information here.<ref name="ref1" /> | Please input information here.<ref name="ref1" /> | ||
===Function=== | ===Function=== | ||
− | + | PSMG3-AS1 regulates cell proliferation and silences PSMG3-AS1 results in a decreased proliferation of H522 and H23 cells.<ref name="ref1" /> | |
− | ===Regulation=== | + | ===Regulation=== |
− | The miR-449b-5p is able to target PSMG3-AS1 to suppress cancer cell proliferation.<ref name="ref1" /> | + | [[File:PSMG3-AS1.jpeg|thumb|300px|MiR-449b-5p targeted PSMG3-AS1 to suppress cancer cell proliferation.<ref name="ref1"/>]] |
+ | The miR-449b-5p is able to target PSMG3-AS1 to suppress cancer cell proliferation.<ref name="ref1" /> | ||
+ | |||
===Expression=== | ===Expression=== | ||
PSMG3-AS1 is upregulated in LUAD,miR-449b-5p can target PSMG3-AS1 to suppress cancer cell proliferation.<ref name="ref1" /> | PSMG3-AS1 is upregulated in LUAD,miR-449b-5p can target PSMG3-AS1 to suppress cancer cell proliferation.<ref name="ref1" /> | ||
Line 25: | Line 27: | ||
==Labs working on this lncRNA== | ==Labs working on this lncRNA== | ||
*Department of Pathology, the 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), NO.789 East Suzhou Street, New Urban Area, Urumqi, 830000, Xinjiang, China.<ref name="ref1" /> | *Department of Pathology, the 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), NO.789 East Suzhou Street, New Urban Area, Urumqi, 830000, Xinjiang, China.<ref name="ref1" /> | ||
− | ==References== | + | ==References== |
+ | <references> | ||
<ref name="ref1">Yue N, Ye M, Zhang R, Guo Y. MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma. BMC Pulm Med. 2020 May 29;20(1):152. doi: 10.1186/s12890-020-01189-5.</ref>(1) | <ref name="ref1">Yue N, Ye M, Zhang R, Guo Y. MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma. BMC Pulm Med. 2020 May 29;20(1):152. doi: 10.1186/s12890-020-01189-5.</ref>(1) | ||
</references> | </references> |
Latest revision as of 04:01, 19 February 2021
LncRNA PSMG3-AS1 can suppress cancer cell proliferation in lung adenocarcinoma[1]
Contents
Annotated Information
Name
Approved symbol:PSMG3-AS1
Approved name:PSMG3 antisense RNA 1 (head to head)
HGNC ID:22230
Alias symbol:KIAA1908
RefSeq ID:NR_021487
LncBook ID:HSALNG0055664
Characteristics
Please input information here.[1]
Function
PSMG3-AS1 regulates cell proliferation and silences PSMG3-AS1 results in a decreased proliferation of H522 and H23 cells.[1]
Regulation
The miR-449b-5p is able to target PSMG3-AS1 to suppress cancer cell proliferation.[1]
Expression
PSMG3-AS1 is upregulated in LUAD,miR-449b-5p can target PSMG3-AS1 to suppress cancer cell proliferation.[1]
Diseases
Lung adenocarcinoma(LUAD)[1]
Labs working on this lncRNA
- Department of Pathology, the 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), NO.789 East Suzhou Street, New Urban Area, Urumqi, 830000, Xinjiang, China.[1]